NEXGEL, Inc. (NXGL) stock news
The latest NEXGEL, Inc. news and press releases. 0 news stories in the last 24 hours. NXGL stock report · Market news
Latest news
- NEXGEL, Inc. (NXGL) Discusses Strategic Platform Reorganization and Refocus on Medical Device and Biomedical Innovation Transcript Seeking Alpha, Sep 25, 3:19 AM UTC
NEXGEL, Inc. (NXGL) Discusses Strategic Platform Reorganization and Refocus on Medical Device and Biomedical Innovation Transcript
Press releases
- NEXGEL Announces Noteholder Participation in Strategic Recapitalization and Approximately $1.2 Million in New Capital Funding GlobeNewsWire, Nov 11, 2:00 PM UTC
Approximately 95% of Outstanding Convertible Note Principal Committed to Conversion, Subject to Completion of a Strategic Merger - NEXGEL Regains Compliance with Nasdaq Listing Requirement GlobeNewsWire, Oct 27, 12:30 PM UTC
LANGHORNE, Pa., Oct. 27, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL), a company with a patient-centric medical technology sales and marketing team working closely with clinicians t... - NEXGEL Announces Dial-In Details for Investor Update Call GlobeNewsWire, Sep 23, 1:29 PM UTC
LANGHORNE, Pa., Sept. 23, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: "NXGL"), a company with a patient centric medical technology sales and marketing team working closely with clinician... - NEXGEL Announces Date for Investor Update Call GlobeNewsWire, Sep 16, 1:29 PM UTC
LANGHORNE, Pa., Sept. 16, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: "NXGL"), a company with a patient centric medical technology sales and marketing team working closely with clinician... - NEXGEL ANNOUNCES LEADERSHIP TRANSITION AND STRATEGIC REVIEW INITIATIVE Globe News Wire, Aug 20, 8:05 PM UTC
LANGHORNE, Pa. , Aug. 20, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: "NXGL") today announced a series of leadership, governance and strategic initiatives designed to strengthen operatio...
Headlines link to their publishers. Research data, not investment advice.